Article, see p 1317 I t has been 13 years since Enriquez-Sarano et al 1 reported the prognostic importance of effective regurgitant orifice area (EROA) and, to a lesser degree, regurgitant volume (RV) in asymptomatic "organic" mitral regurgitation (MR), thus emphasizing the importance of quantitative echo-Doppler assessment to determining MR severity. The study highlighted the proximal isovelocity surface area (PISA) and quantitative Doppler approaches, with recognition of caveats to the PISA approach in patients with mitral prolapse, which has been previously noted by their group. 2, 3 In this issue of Circulation, Antoine et al 4 revisit these concepts, again demonstrating the relation between EROA and RV with survival and making a compelling argument for calculating EROA and RV as components of the echocardiographic assessment of MR severity.
COMPARISON WITH PRIOR PROOF OF CONCEPT STUDY
The current study is very similar to that reported in 2005 but with a much larger study group (3914 in the current versus 456 in the 2005 report) and with longer follow-up (10 versus 5 years). This larger sample size allows the authors to consider EROA as a continuous variable rather than having values bucketed into mild, moderate, and severe categories. This, in turn, delivers a message that is clinically more compelling, particularly as it relates to the absence of a plateau effect for EROA (ie, although both "severe," an EROA of 80 mm 2 implies a worse prognosis than 40 mm 2 ). Both studies have evaluated patients with degenerative mitral regurgitation-in the current study exclusively, and in the former study, in the "majority." The patient demographics were similar, with higher prevalence of men in the moderate and severe MR groups (based on EROA) and higher prevalence of women in the mild MR group. The number of patients with flail is not provided in the 2005 study but, interestingly, in the current study, flail accounts for 2% of those with an EROA <20mm 2 and 17% of those with an EROA of 20-39 mm 2 , respectively, challenging the assumption that all flail leaflets are associated with severe MR.
The results of the current and 2005 studies support the prognostic significance of EROA and RV, with EROA being the stronger predictor of all cause mortality. In the current study, the argument is strengthened by comparing observed to expected mortality. However, there are differences in the absolute numbers that are not discussed, with poorer 5-year survival in the EROA of 20 to 39 mm 2 group in the original versus current reports (66%) versus the current report (≈75%). Results for other groups are similar. Whether these are attributable to methodologic differences is uncertain. For example, the study of 2005 excluded patients with nonholosystolic MR where EROA by PISA may misleadingly overestimate the MR severity. 2 In addition, the 2005 study included asymptomatic patients but did not exclude patients with other class I or "strong" II indications for surgery (EF <60%, LVESD≥40 mm, pulmonary artery systolic pressure >50%, and atrial fibrillation). The current study included all comers but performed a subgroup analysis of those with none of these surgical indications. In this subgroup, EROA remained associated with mortality. It would be interesting to know whether all patients with surgical indications had severe MR based on EROA or RV. The comparison to other approaches of grading MR was limited to those based primarily on jet dimensions, whereas in the current study, it appears that a more integrated approach was used for comparison, although little detail is provided.
ROUTINE PRACTICE
Both studies based their analysis on echocardiograms performed at the Mayo Clinic Rochester, recognized as one of the strongest and most comprehensive echocardiography centers, and thus the analyses may not be generalizable to other centers. Although the current study emphasizes the "routine practice" aspect of the analysis, the authors are being modest in equating the Mayo Rochester laboratory with the real world practice of echocardiography. This concern is reinforced by the particular challenges of the quantitative Doppler approach. 5 In this regard, a truly real-world study would be informative although difficult to do. It is notable that the Intersocietal Commission has helped improve the quantitation of aortic stenosis by making continuity equation determination of aortic valve area a requirement for laboratory accreditation. Perhaps, based on the clinical importance of MR, there should also be some requirement for quantitation of MR as recommended by societal guidelines and as supported by the current study.
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LIMITATION AND IMPLICATIONS FOR CLINICAL DECISION MAKING
In many ways, the current study has similar limitations to its precursor where most patient data are available at only a single entry time point. Information as to the progression of severity, complete disclosure of the prevalence of surgical indications at baseline, information as to their onset over the follow-up period are lacking, and the approach to medical management and surgical decision making is not standardized. Thus, it offers little to the ongoing debate about early intervention versus medical management (watchful waiting) for patients with degenerative MR. Indeed, even for prognosis, it is difficult to extrapolate these data to clinical decision making for an individual patient.
A number of other limitations should be noted. First, outcomes in this study are based on a group of patients, many of whom had severe MR by EROA and hard indications for intervention either at baseline or during follow-up but who may not have undergone surgery. Perhaps some of these patients were considered high-risk surgical candidates with comorbidities that may have affected survival. For this reason, it is somewhat misleading to characterize this as a study of prognostic indicators for patients "under medical management." Second, the authors did not provide any data regarding the other echocardiographic parameters available to the clinical interpreters. One assumes that they were considering at least EROA and RV in that assessment, but how they were weighted is unclear because the guidelines provide no guidance as to how to deal with discordant indices of severity. Third, the authors used 2 distinctly different methods to calculate EROA-PISA and quantitative Doppler-without distinguishing which method performed best. They indicate that EROA and RV were determined by quantitative Doppler in 1193, PISA in 2622, and both in 1155, but no detail is provided as to the concordance between the 2 approaches when both were performed. This would be extremely informative and would impact the clinical implications of the study. Whereas PISA approaches are widely deployed, the quantitative Doppler approach is particularly challenging. 5 For example, this method requires meticulous time-consuming attention to precise sample volume positioning at the level of mitral annulus in diastole, keeping in mind that there is substantial apex-to-base motion of this nonplanar structure. Fourth, as the authors note, recent studies have shown significant discordance between PISA and MRI-derived RV, with MRI assessment being more reproducible and a better predictor of postoperative remodeling and echocardiography tending to overestimate MRI-derived RV. 7 It would be interesting to know how many patients with "severe" MR EROAs were not felt to have severe MR using the integrated echocardiographic approach.
CONCLUSIONS
This study confirms the findings of the 2005 study, with a larger but similar study group, and demonstrates that there is no plateau effect to the prognostic importance of EROA. The authors have provided important evidence supporting the current emphasis on quantitative approaches to assessing the severity of degenerative MR. These methods provide important tools for grading of MR that would provide the foundation for the randomized trials of medical versus surgical management and that will be essential to inform clinical decision making.
